Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05573503
Other study ID # SexCanWebEdNurse
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date October 14, 2022
Est. completion date March 31, 2024

Study information

Verified date March 2023
Source Karlstad University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the SexCan - WebEd Nurse study is to evaluate the effect of a five week online university course, "Bring it up - Assessment and support of patients' sexuality in cancer nursing", aimed at cancer nurses, on occupational self-efficacy and attitudes towards addressing sexuality with patients.


Description:

Cancer nurses attending the course will be recruited. Effects will be used with a pre-post design at two occasions or until we reach 15 participants. Survey data will be collected at baseline and two times post the course. Qualitative interviews with participants will also be performed as well as observational data from the seminars in the course. The participants' ward managers will also be invited to qualitative interviews considering how to implement the nurses' new knowledge clinically.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 18
Est. completion date March 31, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Registered nurses working as a contact nurses in cancer care who are admitted to the intervention university course. Exclusion Criteria: - N/A.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Bring it up - Assessment and support of patients' sexuality in cancer nursing
Participants will attend a five week online university course, "Bring it up - Assessment and support of patients' sexuality in cancer nursing". The course addresses theories and models about sexuality in relation to cancer illness, conversation techniques, models for addressing sensitive topics, methods for assessing the impact of cancer on sexuality, methods for preventing and treating sexual problems in relation to cancer, relevant nursing interventions for person-centred counselling about sexuality, and ethical aspects. The teaching consists of literature, online lectures, seminars, clinical practice, and written exams. A university certificate will be issued to participants who pass all exams.

Locations

Country Name City State
Sweden Karlstad University Karlstad Värmland

Sponsors (1)

Lead Sponsor Collaborator
Karlstad University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Occupational Self-Efficacy (from baseline to 5 weeks post finished intervention) Measured with the "Short Occupational Self-Efficacy Scale". This instrument ranges from 6 to 36 points, where higher values indicate a higher grade of self-efficacy. At baseline and then 5 weeks post finished intervention.
Primary Change in Occupational Self-Efficacy (from baseline to 19 weeks post finished intervention) Measured with the "Short Occupational Self-Efficacy Scale" At baseline and then 19 weeks post finished intervention.
Primary Change in Attitudes towards addressing sexuality (from baseline to 5 weeks post finished intervention) Measured with the "Sexual Health - Extended Version - Swedish (PASH-Ext-S)". The instrument ranges from 27 to 135 points. Higher values indicate a higher degree of positive attitudes to addressing sexuality. At baseline and then 5 weeks post finished intervention.
Primary Change in Attitudes towards addressing sexuality (from baseline to 19 weeks post finished intervention) Measured with the "Sexual Health - Extended Version - Swedish (PASH-Ext-S)" At baseline and then 19 weeks post finished intervention.
Secondary Change in Knowledge about the influence of cancer on sexuality (from baseline to 5 weeks post finished intervention) Study specific questionnaire At baseline and then 5 post finished intervention.
Secondary Change in Knowledge about the influence of cancer on sexuality (from baseline to 19 weeks post finished intervention) Study specific questionnaire At baseline and then 19 weeks post finished intervention.
Secondary Change in Number of conversations with patients relating to sexuality (from baseline to 5 weeks post finished intervention) At baseline and then 5 weeks post finished intervention.
Secondary Change in Number of conversations with patients relating to sexuality (from baseline to 5 weeks post finished intervention) At baseline and then 19 weeks post finished intervention.
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Terminated NCT03166631 - A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread Phase 1
Completed NCT01938846 - BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors Phase 1
Recruiting NCT06058312 - Individual Food Preferences for the Mediterranean Diet in Cancer Patients N/A
Completed NCT03308942 - Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants Phase 2
Recruiting NCT06018311 - Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads N/A
Withdrawn NCT05431439 - Omics of Cancer: OncoGenomics
Completed NCT01343043 - A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Phase 1
Completed NCT01938638 - Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer Phase 1
Recruiting NCT05514444 - Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) Phase 1
Recruiting NCT02292641 - Beyond TME Origins N/A
Terminated NCT00954512 - Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) Phase 1/Phase 2
Recruiting NCT04958239 - A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) Phase 1
Recruiting NCT04627376 - Multimodal Program for Cancer Related Cachexia Prevention N/A
Completed NCT01222728 - Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
Recruiting NCT06004440 - Real World Registry for Use of the Ion Endoluminal System
Active, not recruiting NCT05636696 - COMPANION: A Couple Intervention Targeting Cancer-related Fatigue N/A
Not yet recruiting NCT06035549 - Resilience in East Asian Immigrants for Advance Care Planning Discussions N/A
Recruiting NCT06004466 - Noninvasive Internal Jugular Venous Oximetry
Not yet recruiting NCT02806557 - Profiling Neutrophil Counts in Patients on Chemotherapy N/A